Trial Profile
Single-blind, crossover trial of Lisdexamfetamine (LDX) and Mixed Amphetamine Salts - Immediate release (MAS-IR) in adult Attention Deficit Hyperactivity Disorder (ADHD) patients
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 22 Jan 2018
Price :
$35
*
At a glance
- Drugs Lisdexamfetamine (Primary) ; Mixed amfetamine salts
- Indications Attention-deficit hyperactivity disorder
- Focus Therapeutic Use
- 14 Oct 2015 New trial record